SCARSDALE, N.Y., April 19, 2018 -- Dr. Neal Goldberg, a Westchester County plastic surgeon, explains how patients should be aware of the three primary types of eyelid surgery to determine which approach or approaches can help achieve their functional and cosmetic goals.
|
|||||
Medically known as blepharoplasty, Dr. Goldberg says that eyelid surgery can be broken down into three main categories: upper blepharoplasty, lower blepharoplasty, and Asian blepharoplasty (or double-eyelid surgery). Each main category may also have several possible techniques that can be used to achieve the same objective. Dr. Goldberg notes that lower blepharoplasty and Asian double-eyelid surgery are designed for cosmetic enhancement, while upper blepharoplasty can be performed for aesthetic or functional reasons.
In upper eyelid surgery, excess skin and fat and loose muscles can be trimmed and tightened to restore a more youthful appearance to the eye area. Dr. Goldberg adds that, for some patients, excess skin can become severe enough to obstruct their vision. In this case, the loose tissue is removed to widen the range of sight, a medical more than cosmetic concern.
In lower eyelid surgery, Dr. Goldberg says excess tissue is also removed, but the most common concern is excess fatty tissue, which can cause a “baggy” effect in the under-eye area. In many instances, Dr. Goldberg says patients may wish to rejuvenate the upper and lower eyelids at the same time for more comprehensive cosmetic improvement and to ensure the results are as balanced and harmonious as possible.
For double-eyelid surgery, individuals with a “monolid,” which commonly includes people of Asian descent, can create a crease in their eyelids for a different aesthetic effect. Dr. Goldberg explains that some patients prefer the appearance of a double eyelid, and this procedure can help them achieve that goal.
As with any surgical procedure, Dr. Goldberg says it is important for patients to discuss their concerns and goals with an experienced and board-certified plastic surgeon. An extensively trained physician can review the individual’s medical history and characteristics to determine if they are a good candidate for the procedure, or if another technique may be more effective.
Dr. Goldberg says that elective procedures generally will not be covered by medical insurance; however, if a patient is receiving upper eyelid surgery to address excess skin that is blocking their range of vision, all or part of the procedure may be included in a policy. He recommends people considering this procedure speak with their medical insurance agent to determine their benefits before making a decision. Dr. Goldberg adds that many physicians offer plastic surgery financing options as a convenience for their patients.
About Neal Goldberg, MD, FACS
Dr. Neal Goldberg is a board-certified plastic surgeon in private practice in the Scarsdale, Dobbs Ferry, and Westchester area. A Fellow of the American College of Surgeons, Dr. Goldberg is also an active member of several distinguished medical associations, including the American Society of Plastic Surgeons. He actively participates in continuing education courses, and he is extensively trained in reconstructive and cosmetic procedures of the face, breasts, and body. Dr. Goldberg is available for interview upon request.
For more information about Dr. Goldberg and his practice, please visit doctorgoldberg.com and facebook.com/nealgoldbergmd.
To view the original source of this press release, click here: https://www.doctorgoldberg.com/news-room/westchester-plastic-surgeon-discusses-types-of-eyelid-surgery/
Contact:
Neal D. Goldberg, MD, FACS
Scarsdale Office:
495 Central Park Ave.
Scarsdale NY 10583
(914) 722-1600
Dobbs Ferry Office:
128 Ashland Ave.
Dobbs Ferry, NY 10522
(914) 722-1600
Rosemont Media
(858) 200-0044
www.rosemontmedia.com
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/34200ea7-2b76-4097-882a-9e5f20e12345


TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 



